Market

CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy

CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy
Read More

Related Posts

Ex-South Korea President Yoon tried to provoke Pyongyang into armed aggression, prosecutor says

Ex-South Korea President Yoon tried to provoke Pyongyan...

Jefferies upgrades Red Robin stock to Buy on attractive valuation

Jefferies upgrades Red Robin stock to Buy on attractive...

'Unspeakable tragedy': Bondi residents react to mass shooting

'Unspeakable tragedy': Bondi residents react to mass sh...

Morgan Stanley downgrades HCA Healthcare stock on peak valuation concerns

Morgan Stanley downgrades HCA Healthcare stock on peak ...

Currencies on guard ahead of major central bank decisions, US data releases

Currencies on guard ahead of major central bank decisio...

KLA stock rating upgraded to Buy by Jefferies on strong chip demand outlook

KLA stock rating upgraded to Buy by Jefferies on strong...